Cargando…

Evaluation of Ischemia-Modified Albumin, Malondialdehyde, and Advanced Oxidative Protein Products as Markers of Vascular Injury in Diabetic Nephropathy

AIM: This study aimed at evaluation of ischemia-modified albumin (IMA), malondialdehyde (MDA), and advanced oxidative protein products (AOPP) as markers of vascular injury in diabetic nephropathy (DN) with derivation of cutoff values for the same. MATERIALS AND METHODS: Study population comprised 60...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Afzal, Manjrekar, Poornima, Yadav, Charu, Agarwal, Ashish, Srikantiah, Rukmini Mysore, Hegde, Anupama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854310/ https://www.ncbi.nlm.nih.gov/pubmed/27158221 http://dx.doi.org/10.4137/BMI.S39053

Ejemplares similares

Indices of Glucose Homeostasis in Cord Blood in Term and Preterm Newborns
por: Ahmad, Afzal, et al.
Publicado: (2016)

Evaluation of Minimum Inhibitory Concentration of Heavy Metals Contained in Packaging Material Digest on Prominent Gut Microbiota
por: Mukhi, Senna, et al.
Publicado: (2023)

Increased ischemia-modified albumin and malondialdehyde levels in videothoracoscopic surgery
por: Oncel, Mufide, et al.
Publicado: (2016)

Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss
por: Christy, Alap L., et al.
Publicado: (2014)

The Role of Ischemia-modified Albumin and Ischemia-Modified Albumin to Albumin Ratios in Patients with Alopecia Areata
por: Tanacan, Efsun, et al.
Publicado: (2023)

Do Premenopausal Hypothyroid Women on Levothyroxine Therapy Need Bone Status Monitoring?
por: Babu, Ruby P, et al.
Publicado: (2015)

Comparison of malondialdehyde levels and superoxide dismutase activity in resveratrol and resveratrol/donepezil combination treatment groups in Alzheimer’s disease induced rat model
por: Rao, Y. Lakshmisha, et al.
Publicado: (2021)

Evaluation of the Relationship Between Microalbuminuria and Urine Ischemia‐Modified Albumin Levels in Patients with Diabetic Nephropathy
por: Bilgi, Mustafa, et al.
Publicado: (2016)

Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI)
por: Aladağ, Nesim, et al.
Publicado: (2021)

Ischemia-Modified Albumin: Origins and Clinical Implications
por: Shevtsova, Alla, et al.
Publicado: (2021)

Ischemia-modified albumin must be evaluated as an oxidative stress marker together with albumin and bilirubin in individuals with acute appendicitis
por: Reddy, Varikasuvu Seshadri, et al.
Publicado: (2015)

Investigation of ischemia modified albumin, oxidant and antioxidant markers in acute myocardial infarction
por: Hazini, Ahmet, et al.
Publicado: (2015)

Ischemia modified albumin as a useful marker for diagnoses and management of diabetic retinopathy
por: Kumar, Winay, et al.
Publicado: (2022)

The Role of Ischemia Modified Albumin in Acute Pulmonary Embolism
por: Kaya, Zeynettin, et al.
Publicado: (2014)

The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia
por: Karaşin, Süleyman Serkan, et al.
Publicado: (2020)

Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease
por: Omma, Ahmet, et al.
Publicado: (2018)

Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium()()
por: Savci, Unsal, et al.
Publicado: (2020)

Ischemia-Modified Albumin—A Potential New Marker of Oxidative Stress in Dermatological Diseases
por: Tampa, Mircea, et al.
Publicado: (2022)

Ischemia-Modified Albumin Levels in Children with Chronic Liver Disease
por: Cakir, Murat, et al.
Publicado: (2012)

Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis
por: Aydin, Ozgur, et al.
Publicado: (2014)

Ischemia Modified Albumin Can Predict Necrosis at Incarcerated Hernias
por: Kadioğlu, Hüseyin, et al.
Publicado: (2013)

Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery
por: Hartley, Adam, et al.
Publicado: (2022)

Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
por: Mashitah, Musthika Wida, et al.
Publicado: (2015)

Serum Albumin Modifies the Effect of Peripheral Blood Monocytes on Severity of Diabetic Nephropathy
por: Cristancho, Cagney
Publicado: (2021)

Malondialdehyde-Modified Photoreceptor Outer Segments Promote Choroidal Neovascularization in Mice
por: Chen, Yuhong, et al.
Publicado: (2022)

Amadori albumin in diabetic nephropathy
por: Neelofar, Km., et al.
Publicado: (2015)

Ischemia modified albumin: does it change during pneumoperitoneum in robotic prostatectomies?
por: Ozgen, Serpil Ustalar, et al.
Publicado: (2016)

Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding
por: Coverdale, James P.C., et al.
Publicado: (2018)

Role of ischemia-modified albumin in patients with acute decompensated heart failure
por: Pan, Defeng, et al.
Publicado: (2016)

Correlation between ischemia-modified albumin level and coronary collateral circulation
por: Chen, Xin, et al.
Publicado: (2020)

Evaluation of the role of ischemia modified albumin in neonatal hypoxic-ischemic encephalopathy
por: Talat, Mohamed A., et al.
Publicado: (2020)

Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy
por: Pavlovschi, Ecaterina, et al.
Publicado: (2021)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
por: Merendino, Rosaria Alba, et al.
Publicado: (2003)

Malondialdehyde as a Marker of Oxidative Stress in Periodontitis Patients
por: Cherian, Deepthi A., et al.
Publicado: (2019)

Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of “N-Terminal Modification” to “Fatty Acid Occupation” of Albumin
por: Oran, Ismail, et al.
Publicado: (2017)

The Effect of Continuous Ventilation on Thiol-Disulphide Homeostasis and Albumin-Adjusted Ischemia-Modified Albumin During Cardiopulmonary Bypass
por: Ozgunay, Seyda Efsun, et al.
Publicado: (2019)

Ischemia-Modified Albumin, a Novel Predictive Marker of In-Hospital Mortality in Acute Aortic Dissection Patients
por: Yang, Guifang, et al.
Publicado: (2019)

Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60‐Year‐Olds
por: Thiagarajan, Divya, et al.
Publicado: (2016)

The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
por: Turedi, Suleyman, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9k71esbvpum544n0v5puqgj6gs